Under the umbrella of Dissemination and Communication strategy
We are pleased to invite you to join us for PharmaLedger’s second open webinar bringing together our members to present and discuss the current state of our blockchain-enabled use cases related to Clinical Trials and Health Data.
This is part of a series of webinars aimed at fostering greater alignment and a common understanding of PharmaLedger’s activities, approaches, and progress among its members and the general public.
PharmaLedger Project Coordinator, Maria Eugenia (Xenia) Beltran (Universidad Politécnica de Madrid) will deliver the introduction to PharmaLedger as well as the context of the selected use cases for this webinar.
- 3rd Mar at 10:00am CET
The PharmaLedger Clinical Trial Recruitment Patient Matching Solution
In this presentation, we uncover PharmaLedgers plans to streamline patient discovery and participation in clinical research through a neutral, industry-wide utility for matching patients to clinical trials.
Blockchain is not just for cryptocurrency! PharmaLedger is helping reshape eConsent.
In the first presentation of this webinar, we explore the value that using blockchain can have on the informed consent form (ICF) process and how this approach can reduce the administrative burden of clinical trials. More importantly how blockchain can help build an ecosystem which enables trust and transparency to all of its stakeholders.
Hernando C. GiraldoBoehringer Ingelheim
Using connected health devices and remote patient monitoring (RPM) technologies to provide quality data to support patient health records.
This use case aims at validating how blockchain enhances and supports the dynamic acquisition and processing of data from patients and medical devices in one consolidated view, to accelerate clinical development and bring solutions to patients earlier.
Disa Lee ChounUCB
Francesca RocchiBambino Gesù Children Hospital
Empowering patients through personalised medicine.
In the concluding presentation of this webinar, we will provide a general overview of our personalised medicine use case. Here, we aim to establish a trusted environment that supports patient-centric solutions to improve the process of diagnosis, prevention, and personalised treatments of patients.
Beatriz MerinoUniversidad Politécnica de Madrid
Christos KontogiorgisDemocritus University of Thrace